Silenseed announced the construction of a class-A GMP clean room facility

Modi’in, Israel, Dec. 31, 2015 – Silenseed, a leading RNAi-based therapeutics company, today announced the construction of a class-A GMP clean room facility in the new company office Modi’in. The new facility will enable in-house production of the company’s lead product, KRAS-LODER, to support the Phase 2 study in Locally Advanced Pancreatic Cancer (NCT01676259)

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email